Pharming (PHAR) Total Current Liabilities (2019 - 2025)
Historic Total Current Liabilities for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $87.9 million.
- Pharming's Total Current Liabilities rose 1011.41% to $87.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.9 million, marking a year-over-year increase of 1011.41%. This contributed to the annual value of $73.8 million for FY2024, which is 534.32% down from last year.
- Pharming's Total Current Liabilities amounted to $87.9 million in Q3 2025, which was up 1011.41% from $87.9 million recorded in Q2 2025.
- In the past 5 years, Pharming's Total Current Liabilities ranged from a high of $207.3 million in Q1 2024 and a low of $46694.0 during Q3 2022
- Its 5-year average for Total Current Liabilities is $63.8 million, with a median of $65.0 million in 2023.
- Per our database at Business Quant, Pharming's Total Current Liabilities plummeted by 9990.01% in 2022 and then soared by 14565320.17% in 2023.
- Quarter analysis of 5 years shows Pharming's Total Current Liabilities stood at $47206.0 in 2021, then surged by 126362.82% to $59.7 million in 2022, then soared by 30.6% to $78.0 million in 2023, then dropped by 5.34% to $73.8 million in 2024, then rose by 19.12% to $87.9 million in 2025.
- Its Total Current Liabilities was $87.9 million in Q3 2025, compared to $87.9 million in Q2 2025 and $77.5 million in Q1 2025.